- Home
- SNFCA vs RNAC Comparison
SNFCA vs RNAC Comparison
Compare SNFCA & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNFCA | RNAC |
|---|---|---|
| Founded | 1965 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.9M | 168.3M |
| IPO Year | 1995 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SNFCA | RNAC |
|---|---|---|
| Price | $9.65 | $6.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 33.4K | ★ 147.0K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.51 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $344,587,538.00 | $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.68 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $7.70 | $5.60 |
| 52 Week High | $11.00 | $14.56 |
Technical Indicators
Market Signals| Indicator | SNFCA | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 48.99 |
| Support Level | $8.38 | $5.89 |
| Resistance Level | $9.78 | $6.60 |
| Average True Range (ATR) | 0.21 | 0.43 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 73.08 | 80.40 |
Price Performance
Historical ComparisonAbout SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.